EMERGING TESTS

Whole-Genome Sequencing Adds Value to Cardiomyopathy Workup

Whole-genome sequencing (WGS) identifies additional genetic causes of hypertrophic cardiomyopathy (HCM) beyond those identified through targeted gene sequencing approaches, according to a study … [Read more...]

SPECIAL FOCUS

Noninvasive Gene Expression Test for Melanoma Cuts Costs

The noninvasive pigmented lesion assay (PLA; DermTech) reduces costs compared to the current standard of care for diagnostic workup of pigmented skin lesions suggestive of melanoma, according to a … [Read more...]

PRECISION MEDICINE

Next-Gen Sequencing Has Significant Utility for Drug-Resistant Epilepsy

Next-generation sequencing improves definitive diagnoses for children with drug-resistant epilepsy, according to a pilot study published online June 22 in CNS Neuroscience & Therapeutics. … [Read more...]

PRECISION MEDICINE

General Population Has Interest in Genetic Testing for Skin Cancer Risk

There is moderately high interest and follow through among the general population for genetic testing to determine melanoma skin cancer risk, according to a study published in JAMA Dermatology. … [Read more...]

PUBLIC HEALTH

Procalcitonin Results Fail to Guide Lower Antibiotic Use

Procalcitonin assays results did not help emergency department and hospital-based clinicians prescribe fewer antibiotics for patients presenting with suspected lower respiratory tract infection, … [Read more...]

GUIDELINES AT A GLANCE

FDA Recommends Pooled of Blood Testing for Zika Virus

The U.S. Food and Drug Administration (FDA) revised recommendations for testing donated blood for Zika virus. The agency will now allow pooled testing of blood donations, rather than universal nucleic … [Read more...]

INNOVATION

Urinary cfDNA Analysis Valuable for Urinary Tract Infections

Sequencing of urinary cell-free DNA (cfDNA) offers a comprehensive examination of bacterial and viral infections of the urinary tract and could be a valuable diagnostic tool for both kidney transplant … [Read more...]

PAMA

PAMA Unlocks Golden Age for Innovative Diagnostics

By Chance Scott  bio The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition. When Congress … [Read more...]

PUBLIC HEALTH

HIV Testing Opportunities Missed For High-Risk Patients

There are many missed opportunities for testing and diagnosis of HIV among high-risk individuals seen in clinical settings, according to a research letter published June 26 in the Journal of the … [Read more...]

CO-ORDINATING DATA

Laboratory Information Systems (LIS): What You Need To Know To Get Paid

By Sean McSweeney  bio Today, laboratory billing claims require more and more data to successfully get paid. One of the biggest reasons your claims may be getting denied is because you're … [Read more...]


(-0000g2)